Author:
Cassileth B. R.,Soloway M. S.,Vogelzang N. J.,Chou J. M.,Schellhammer P. D.,Seidmon E. J.,Kennealey G. T.,
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference18 articles.
1. American Cancer Society. Cancer facts & figures?1992, Atlanta, ACS, 1992.
2. Peeling WB. Phase III studies to compare goserelin (Zoladex®) with orchiectomy and with diethylstilbestrol in the treatment of prostatic carcinoma. Urology 1989; 33(suppl 5): 45?52.
3. Cassileth BR, Soloway MS, Vogelzang NJ, et al. Patients' choice of treatment in stage D prostate cancer. Urology 1989; 33(suppl 5): 57?62.
4. Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 1985; 69: 1155?1157.
5. Tannock I, Gospodarowicz M, Meakin W, et al. Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 1989; 7: 590?597.
Cited by
126 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献